Kai Langel DEEP Measures
Since 2000, Kai has been a pioneer in patient-facing solutions for clinical trials working with young innovative technology companies. In 2012, Kai co-founded eClinicalHealth, the developers of the Clinpal remote clinical trial platform. Through his involvement in technical, operational and regulatory roles, he has gained deep understanding of broad aspects of the drug development process and the ecosystem behind it.
Kai combines his innovation mindset and nimble execution with several years of experience working at Johnson & Johnson Innovative Medicine R&D in various roles. Today, Kai leads DEEP Measures Oy as a Founder and CEO, having started this initiative within J&J with DEEP becoming an independent company in 2022. DEEP’s core mission is to accelerate the adoption of harmonized digital measures of health to be transform the way human health is managed.